Sarepta Therapeutics (NasdaqGS:SRPT) saw its share price rise by 19% over the past month, a move that notably outpaced the broader market's 1% increase for the week and the 13% gain over the year.

With modern improvements in mass properties and the concept of forgiveness on off-center hits, there’s always a lot of ...

Donna Tennent, whose son participated in the MiSight® 1 day trial, shares her family’s experience of myopia management ...

A novel shape-based automatic reference control point and feature ... due to invariance of its facial feature vector. The theoretical performance analysis of the proposed technique was provided by a ...